frovatriptan has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaltoft, AK; Kasch, H; Møller-Helgestad, OK | 1 |
| Feuerstein, G; Gagnon, R; Koster, P; Parsons, AA; Raval, P; Tilford, N; Valocik, R | 1 |
2 other study(ies) available for frovatriptan and Cardiovascular Stroke
| Article | Year |
|---|---|
[Frovatriptan possibly causing acute myocardial infarction].
Topics: Carbazoles; Female; Headache Disorders, Secondary; Humans; Middle Aged; Migraine Disorders; Myocardial Infarction; Serotonin Receptor Agonists; Tryptamines | 2015 |
Effects of the novel antimigraine agent, frovatriptan, on coronary and cardiac function in dogs.
Topics: Animals; Blood Pressure; Carbazoles; Cardiac Output; Coronary Circulation; Dogs; Female; Heart; Heart Rate; In Vitro Techniques; Male; Migraine Disorders; Myocardial Infarction; Serotonin Receptor Agonists; Tryptamines | 1998 |